Patent · US Active

Antigenically matched influenza vaccines

US11013795B2 · kind B2 · utility

0Cited by

1References

23Claims

0Family size

Assignee

Seqirus UK Limited · GB

Inventors

Ethan Settembre · Cambridge, US
Philip Dormitzer · Cambridge, US

Key dates

Filing date	Jun 24, 2016
Grant date	May 25, 2021
Priority date	—
Expiry date	Jul 23, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2760/16134
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are influenza vaccine compositions, related preparations and intermediates, formulations, production methods, immunization methods, and use thereof, for achieving improved immune-protection in human subjects. More specifically, non-egg-based influenza vaccines are described, which provide improved antigenic match.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.